慢性硬膜下血肿钻孔引流后骨膜下与硬膜下引流管比较:随机临床试验
这项多中心前瞻性随机对照非劣效性试验纳入220例慢性硬膜下血肿钻孔引流患者,比较骨膜下引流管(SPD)与硬膜下引流管(SDD)的12个月复发再手术率。SPD组复发率8.33%(95%CI 4.28-14.72),SDD组12.00%(95%CI 6.66-19.73),治疗差异3.67%(95%CI -12.6-5.3)未达到预设非劣效界值3.5%。SPD组手术感染率和引流管置入所致医源性并发症率显著更低,住院时间和死亡率两组相当。
要点
- SPD组12个月复发再手术率8.33%,SDD组12.00%,未达非劣效界值。
- 两组住院时间和死亡率相当,SPD可能适合常规临床实践。
核心结论
- 虽然未达到非劣效性标准,但骨膜下引流管置入与更低的复发率、更少的手术感染和更低的引流管错位率相关。
- 这些发现提示骨膜下引流管可能在常规临床实践中值得采用。
研究设计与样本
- 多中心、前瞻性、随机、对照、非劣效性试验,分析18岁及以上接受慢性硬膜下血肿钻孔引流的患者。
- 血肿清除后随机分配至硬膜下引流管组或骨膜下引流管组,主要终点为12个月内需再手术的复发,非劣效界值3.5%。
- 共220例随机患者全部纳入最终分析(骨膜下引流管组120例,硬膜下引流管组100例)。
主要发现
- 骨膜下引流管组复发率8.33%(95%CI 4.28-14.72),硬膜下引流管组12.00%(95%CI 6.66-19.73)。
- 治疗差异3.67%(95%CI -12.6-5.3),未达到预设非劣效标准。
- 两组住院时间和死亡率相当。
临床怎么用
- 对于慢性硬膜下血肿钻孔引流患者,可考虑使用骨膜下引流管以降低复发、手术感染和引流管错位风险。
- 尽管非劣效性未确立,骨膜下引流管的安全性和部分结局优势支持其在常规实践中的应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of a subdural drain (SDD) after burr-hole drainage of chronic subdural hematoma (cSDH) reduces recurrence at 6 mo. Subperiosteal drains (SPDs) are considered safer, since they are not positioned in direct contact to cortical structures, bridging veins, or hematoma membranes. OBJECTIVE: To investigate whether the recurrence rate after insertion of a SPD is noninferior to the insertion of a more commonly used SDD. METHODS: Multicenter, prospective, randomized, controlled, noninferiority trial analyzing patients undergoing burr-hole drainage for cSDH aged 18 yr and older. After hematoma evacuation, patients were randomly assigned to receive either a SDD (SDD-group) or a SPD (SPD-group). The primary endpoint was recurrence indicating a reoperation within 12 mo, with a noninferiority margin of 3.5%. Secondary outcomes included clinical and radiological outcome, morbidity and mortality rates, and length of stay. RESULTS: Of 220 randomized patients, all were included in the final analysis (120 SPD and 100 SDD). Recurrence rate was lower in the SPD group (8.33%, 95% confidence interval [CI] 4.28-14.72) than in the SDD group (12.00%, 95% CI 6.66-19.73), with the treatment difference (3.67%, 95% CI -12.6-5.3) not meeting predefined noninferiority criteria. The SPD group showed significantly lower rates of surgical infections (P = .0406) and iatrogenic morbidity through drain placement (P = .0184). Length of stay and mortality rates were comparable in both groups. CONCLUSION: Although the noninferiority criteria were not met, SPD insertion led to lower recurrence rates, fewer surgical infections, and lower drain misplacement rates. These findings suggest that SPD may be warranted in routine clinical practice.
引用
- Soleman J, Lutz K, Schaedelin S, et al. Subperiosteal vs Subdural Drain After Burr-Hole Drainage of Chronic Subdural Hematoma: A Randomized Clinical Trial (cSDH-Drain-Trial). Neurosurgery. 2019. PMID: 31194877. doi:10.1093/neuros/nyz095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。